BubR1 Controls Heart Development by Promoting Expression of Cardiogenesis Regulators

BubR1 Controls Heart Development by Promoting Expression of Cardiogenesis Regulators

Background Congenital heart defects are structural anomalies present at birth that can affect the function of the heart. Aneuploidy is a significant risk factor for congenital heart defects. Mosaic variegated aneuploidy syndrome, caused by mutations in Bub1b (encoding BubR1, a mitotic checkpoint pro...

Full description

Saved in:

Bibliographic Details
Main Authors:	Renju Pun, Aradhana Thapa, Sylar R. Takafuji, Rexton M. Suzuki, Gabrielle F. Kay, Toni D. Howard, Michael H. Kim, Brian J. North
Format:	Article
Language:	English
Published:	Wiley 2025-03-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	BubR1 cardiac development congenital heart defects MVA syndrome single‐cell RNA sequencing
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.124.038286
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

BUB1B and gynecological malignant tumors
by: HOU Yiying, WEI Fang
Published: (2024-12-01)

Sod1 deficiency in mouse oocytes during in vitro maturation increases chromosome segregation errors with a reduced BUBR1 at kinetochore
by: Mitsuru Nago, et al.
Published: (2025-01-01)

DTL promotes the growth and migration of melanoma cells through the ERK/E2F1/BUB1 axis
by: Xiuyun Xuan, et al.
Published: (2024-11-01)

Self-priming of Plk1 binding to BubR1 ensures accurate mitotic progression
by: Chunlin Song, et al.
Published: (2024-11-01)

Generation and characterization of two isogenic induced pluripotent stem cell lines from a young female with microcephaly carrying a compound heterozygous mutation in BUB1 gene
by: Anita Ferreira, et al.
Published: (2024-12-01)

Reduced life- and healthspan in mice carrying a mono-allelic BubR1 MVA mutation.
by: Tobias Wijshake, et al.
Published: (2012-01-01)

Overexpression of the Mitotic Checkpoint Genes BUB1 and BUBR1 is Associated with Genomic Complexity in Clear Cell Kidney Carcinomas
by: Mafalda Pinto, et al.
Published: (2008-01-01)

Análisis de Creación de Valor Económico para Empresas del Sector Textil (Value added analysis for the textile sector businesses)
by: Diego Valerio Alfaro, et al.
Published: (2012-12-01)

ANALISIS KINERJA KEUANGAN DENGAN MENGGUNAKAN METODE MARKET VALUE ADDED (MVA) PADA PT. ELECTRONIC CITY INDONESIA TBK YANG TERDAFTAR DI BURSA EFEK INDONESIA (BEI) PERIODE 2019-2023
by: Muhammad Hariv Al Akbar Akbar, et al.
Published: (2024-12-01)

GATA6 regulates WNT and BMP programs to pattern precardiac mesoderm during the earliest stages of human cardiogenesis
by: Joseph A Bisson, et al.
Published: (2025-03-01)

Drosophila CENP-A mutations cause a BubR1-dependent early mitotic delay without normal localization of kinetochore components.
by: Michael D Blower, et al.
Published: (2006-07-01)

RNF20/RNF40 supports the aggressive behavior in cervical cancer by regulating a peroxisome-based anti-ferroptotic mechanism
by: Shaishavi Jansari, et al.
Published: (2025-07-01)

Multi-Antigen Viral-Vectored Vaccine Protects Against SARS-CoV-2 and Variants in a Lethal hACE2 Transgenic Mouse Model
by: Shannon Stone, et al.
Published: (2025-04-01)

Differences in Mpox and Vaccinia Immunity Induced by Non-Replicating and Replicating Vaccinia-Based Vaccines
by: Getahun Abate, et al.
Published: (2025-05-01)

The MVA-VP2-NS1-2A-NS2-Nt vaccine candidate provides heterologous protection in sheep against bluetongue virus
by: Luis Jiménez-Cabello, et al.
Published: (2025-05-01)

Target Trial Emulation of the Modified Vaccinia Ankara-Bavarian Nordic Vaccine for Pre-Exposure Mpox Prevention in At-Risk Populations
by: Clara Suñer, et al.
Published: (2025-05-01)

Sistema innovador de cultivos in vitro inoculados con simbiontes rizosférico MVA y bacterias surfactantes como fitoremediador de suelos contaminados con agrotóxicos
by: Francisco Angel Simòn Ricardo, et al.
Published: (2017-09-01)

The combined vaccination protocol of DNA/MVA expressing Zika virus structural proteins as efficient inducer of T and B cell immune responses
by: Patricia Pérez, et al.
Published: (2021-01-01)

Protection Against Rabies Induced by the Non-Replicative Viral Vectors MVA and Ad5 Expressing Rabies Glycoprotein
by: Debora Patricia Garanzini, et al.
Published: (2025-03-01)

ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2
by: Juan García-Arriaza, et al.
Published: (2025-06-01)

Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge
by: Gerald K. Chege, et al.
Published: (2025-02-01)

A Comprehensive Review of Canine and Feline Ventricular Septal Defects—From Pathogenesis to Long-Term Follow-Up
by: Szymon Graczyk, et al.
Published: (2025-03-01)

Incidence of Congenital Limb Reduction Defects: A Systematic Review
by: Gabrielle Levesque, et al.
Published: (2024-12-01)

Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial
by: Neil Goldstein, et al.
Published: (2024-12-01)

Comparison of spontaneous resolution of secundum atrial septal defects in term and preterm neonates
by: Imtiaz Ahmad, et al.
Published: (2025-05-01)

Maternal Exposure to Ambient Ozone and Fetal Critical Congenital Heart Disease in China: A Large Multicenter Retrospective Cohort Study
by: Yanping Ruan, et al.
Published: (2025-05-01)

Personalized immunization against Mpox Clades I and Ib: Strategies to combat the emerging epidemic
by: Deepak Kumar, et al.
Published: (2025-03-01)

Cervical Spine Injuries and Maxillofacial Trauma: A Systematic Review
by: Feras AlMofreh, DDS, et al.
Published: (2021-12-01)

Experience of parents of children with congenital heart disease: feelings and obstacles
by: Thaís Sena Mombach Barreto, et al.
Published: (2016-02-01)

Experience of parents of children with congenital heart disease: feelings and obstacles
by: Thaís Sena Mombach Barreto, et al.
Published: (2016-02-01)

Congenital Anomalies in Neonates: Findings from Six Baghdad Hospitals
by: Bassam M. Al-Musawi, et al.
Published: (2025-04-01)

TREC and KREC values in patients with congenital heart defects — neonatal screening data
by: L. Yu. Barycheva, et al.
Published: (2024-10-01)

Postoperative delirium in children in undergoing treatment of congenital septal heart defects
by: A. A. Ivkin, et al.
Published: (2021-05-01)

Role of magnetic-resonance imaging of fetus in diagnostics of congenital defects
by: A. M. Korostyshevskaya, et al.
Published: (2012-10-01)

Disparities in Prenatal Diagnosis of Congenital Heart Defects: The Interplay of Insurance and Urbanicity
by: Joyce L. Woo, et al.
Published: (2024-08-01)

Cor triatriatum sinister with partial atrioventricular septal defect in a cat
by: W Go, et al.
Published: (2025-03-01)

Clinical and genetic features of childhood-onset congenital combined pituitary hormone deficiency: a retrospective, single-center cohort study
by: Yoonha Lee, et al.
Published: (2024-12-01)

MVA-HBVac—A novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccination
by: Anna D. Kosinska, et al.
Published: (2025-09-01)

Influences of metabolism and lipid homeostasis on regulatory vs. conventional T cells and implications for autoimmunity
by: Madison A. Nguyen, et al.
Published: (2025-07-01)

Femoral Shortening Osteotomy in Managing Congenital Patellar Dislocation: A Case Report and Review of Literature
by: Samyabrata Das, et al.
Published: (2025-03-01)